Company / Operating Margin
Insulet Corporation Operating Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
17.5%
FY2025
5-year range
2.9% / 17.5%
FY2021-FY2025
Trend
+17.4%
vs FY2024
Sector context
#24 of 143
Health Care
What the data says
Insulet Corporation's operating margin of 17.5% is higher than 83% of companies in the Health Care sector (FY2025). Operating Margin has increased for 3 consecutive years, from 2.9% in FY2022 to 17.5% in FY2025.
Based on SEC 10-K filings.
17.5% in FY2025 with a 5-year CAGR of +11.8%. Top quartile in the Health Care sector.
Improved from 13.0% to 17.5% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- +14.6pp
- 5-Year Change
- +11.8pp
- 10-Year Change
- -
Sector benchmark
Top 17% in Health CareTop 17% of 143This company 17.5% Sector average -295.2%
▼
+105.9% above sector average
Key checks
Key Insights
- Insulet Corporation's operating margin has grown for 3 consecutive years.
- In FY2025, operating margin increased 17.4% year-over-year.
- Currently 312.7pp above the Health Care sector average.
- Lowest operating margin in the period was in FY2016.
Company context
Key Data Points
- Strong profit margin: 20.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 17.5% | +17.4% |
| FY2024 | 14.9% | +15.0% |
| FY2023 | 13.0% | +350.3% |
| FY2022 | 2.9% | -74.9% |
| FY2021 | 11.5% | +101.6% |
| FY2020 | 5.7% | -16.0% |
| FY2019 | 6.8% | +39.3% |
| FY2018 | 4.9% | +403.7% |
| FY2017 | -1.6% | +45.2% |
| FY2016 | -2.9% | +84.2% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026